Jiangsu Topcel-kh Pharmaceutical Co., Ltd.

This early-phase study tests a new type of CAR-T cell therapy that is 'armored' with an anti-PD1 feature to help it fight cancer better. It is for adults with diffuse large B-cell lymphoma that has come back or not responded to standard treatments. The main goals are to check saf…

This early-stage study tests a new type of immune cell therapy (BAFF-R CAR-T) in 30 adults with a specific form of B-cell lymphoma that has not responded to other treatments or has come back. The main goal is to check if the treatment is safe and tolerable. Researchers will also …